Japanese Market Sharply Lower; Down 3%

Losing for the fourth straight session, the Japanese stock market is sharply lower on Friday, following the mixed cues from Wall Street overnight. The benchmark Nikkei 225 is falling 3 percent to below the 36,900 level,

Sensex, Nifty Likely To Extend Losses On Rate Worries, Middle East Tensions

Indian shares look set to extend recent losses on Friday as positive U.S. economic data and hawkish comments from more Fed officials poured cold water on rate-cut hopes.

Asian Markets Trade Sharply Lower

Asian stock markets are trading mostly sharply lower on Friday, following the mixed cues from Wall Street overnight, on ongoing concerns over the tensions in the middle-east with reports of Israel retaliating to last

Sensex, Nifty Extend Losses As Israel Launches Strike On Iran

Indian shares traded lower on Friday to extend losses for a fifth day running as U.S. rate worries lingered and oil prices jumped more than 3 percent on signs of escalating tensions in the Middle East, following reports

Australian Dollar Falls Against Majors

The Australian dollar weakened against other major currencies in the Asian session on Friday.

U.S. Weekly Jobless Claims Unchanged At 212,000

First-time claims for U.S. unemployment benefits remained flat in the week ended April 13th, according to a report released by the Labor Department on Thursday.

Infosys To Acquire German Engineering R&D Services Provider In-tech

Infosys Ltd. (INFY) announced Thursday a definitive agreement to acquire Germany's in-tech, a leading Engineering R&D services provider focused on German automotive industry. The terms of the deal were not disclosed.

Philly Fed Index Unexpectedly Jumps To 15.5 In April

Growth in Philadelphia-area manufacturing activity has unexpectedly seen a considerable acceleration in the month of April, the Federal Reserve Bank of Philadelphia revealed in a report released on Thursday.

Moleculin Biotech Says EMA Grants Orphan Drug Designation To Annamycin To Treat AML

Pharmaceutical company Moleculin Biotech, Inc. (MBRX) announced Thursday that the European Medicines Agency (EMA) has granted Orphan Drug Designation to Annamycin for the treatment of Acute Myeloid Leukemia (AML).

U.S. Jobless Claims Unchanged From Slightly Upwardly Revised Level

First-time claims for U.S. unemployment benefits remained flat in the week ended April 13th, according to a report released by the Labor Department on Thursday. The report said initial jobless claims came in at 212,000,